Ticovac 1.2MCG/0.25 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTLD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,229
Award facts
- Contract value 100% obligated
- $3,228.75 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,228.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TICOVAC 1.2MCG/0.25 vaccine. The contract was awarded on January 14, 2026, with a firm fixed-price structure and no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499,999,999 ceiling value and extends through December 31, 2036.
The PPV-G GEN V program represents the Defense Logistics Agency's broader $30.3 billion pharmaceutical acquisition strategy designed to ensure consistent supply of branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. As a prime vendor under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous delivery orders spanning diverse therapeutic categories and product lines. The company's established performance across multiple pharmaceutical supply requirements positions it as a critical supplier for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTLD?
SPE2DR26FBTLD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBTLD worth?
The government has obligated $3,229 on SPE2DR26FBTLD.
Is contract SPE2DR26FBTLD an order under another contract?
Yes. SPE2DR26FBTLD is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTLD competed?
The extent of competition for SPE2DR26FBTLD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award